{"id":2205,"date":"2024-01-03T10:02:01","date_gmt":"2024-01-03T10:02:01","guid":{"rendered":"https:\/\/healthynewsusa.com\/?p=2205"},"modified":"2024-01-03T10:02:05","modified_gmt":"2024-01-03T10:02:05","slug":"patients-with-narcolepsy-face-a-dual-nightmare-of-medication-shortages-and-stigma","status":"publish","type":"post","link":"https:\/\/healthynewsusa.com\/?p=2205","title":{"rendered":"Patients With Narcolepsy Face a Dual Nightmare of Medication Shortages and Stigma"},"content":{"rendered":"
Nina Shand couldn\u2019t stay awake.<\/p>\n
She had taken afternoon naps since she was a teenager to accommodate her \u201cwork hard, play hard\u201d attitude, but when she was in her mid-20s the sleepiness became more severe.<\/p>\n
Menial computer tasks put her to sleep, and a 20-minute drive across her city, St. Petersburg, Florida, brought on a drowsiness so intense that her eyelids would flutter, forcing her to pull over. She knew something was really wrong when she no longer felt safe behind the wheel.<\/p>\n
In 2021, she received a diagnosis: narcolepsy, a rare disorder that causes excessive daytime sleepiness.<\/p>\n
Her doctor prescribed her Adderall, the brand-name version of the amphetamine-powered medication commonly known for treating attention-deficit\/hyperactivity disorder.<\/p>\n
It worked. For the first time in years, Shand, now 28, felt energized. She was no longer struggling at work, sneaking naps, or downing coffees to trick her body into staying awake. She felt hope.<\/p>\n
But by 2022, a national Adderall shortage meant pharmacies were no longer able to fill her prescription. Shand and countless others across the country were being turned away, left to piece together a new \u2014 and often less effective \u2014 treatment plan with doctors scrambling to meet their needs.<\/p>\n
More than a year later, the shortage continues. In October, Democrats in the U.S. House of Representatives implored the FDA<\/a> and Drug Enforcement Administration <\/strong>to work with drug manufacturers to ensure better supply.<\/p>\n \u201cWe cannot allow this to be the continuing reality for Americans,\u201d read their letter, led by Rep. Abigail Spanberger<\/a> (D-Va.).<\/p>\n But for now, it is.<\/p>\n Each month is accompanied by familiar anxieties as patients navigate a web of messy logistics and uncertainty while trying to get the medication they need to live normally.<\/p>\n Media coverage of the shortage \u2014 and even the House Democrats\u2019 letter \u2014 has focused primarily on the harms to people with ADHD. But for those with sleep disorders, like Shand, the effects may be even more consequential.<\/p>\n Basic tasks \u2014 like driving \u2014 become dangerous or impossible without medication. Job and school performances are threatened by the onset of sudden sleep and sometimes even paralysis. Hobbies and social lives can fall by the wayside, too.<\/p>\n \u201cAdderall gave me my life back,\u201d said Shand. \u201cGoing from having a medication to not, it\u2019s like a roller coaster you desperately want to get off.\u201d<\/p>\n The resulting challenges, she said, have made particularly clear the loneliness of living with a rare and misunderstood disorder.<\/p>\n What Is Narcolepsy?<\/strong><\/p>\n An estimated 1 in 2,000 people in the United States live with narcolepsy \u2014 more than 160,000 people nationwide. The disorder is part of a broader group known as hypersomnolence disorders, or conditions characterized by difficulty staying awake during the day.<\/p>\n There are two major types<\/a> of narcolepsy.<\/p>\n Both types affect one\u2019s ability to stay awake, but Type 2 is typically less severe. In addition to sleep disturbance, most people with Type 1 narcolepsy experience sudden, temporary loss of muscle control or paralysis, called cataplexy.<\/p>\n Cataplexy attacks are typically triggered by emotion \u2014 like laughter or surprise. For one person living with narcolepsy, an attack might look like a slack jaw or limp hand. For another, it could trigger full-body paralysis.<\/p>\n Causes of Type 1 narcolepsy can include autoimmune disorders and brain injuries, but the underlying issue is believed to be low levels of hypocretin, a hormone that is thought to affect REM sleep \u2014 the dream state.<\/p>\n \u201cNarcolepsy is due to a faulty switch in the brain for REM sleep,\u201d said Muhammad Ali Syed<\/a>, a physician and the medical director of the University of Florida Health Sleep Center.<\/p>\n People with narcolepsy go into REM extremely quickly, Syed said. A person without a sleep disorder will enter REM around an hour or 90 minutes after falling asleep. But a person with narcolepsy may go into REM almost immediately and could have a fully fleshed-out dream in just minutes, Syed said.<\/p>\n In some circumstances, symptoms can also include sleep paralysis and hallucinations.<\/p>\n Increased Demand<\/strong><\/p>\n Every week since the Adderall shortage began, Fareeha Hussaini<\/a>, a sleep medicine specialist at University of South Florida Health, has had calls to her office from patients struggling to access their medication.<\/p>\n College students are worried about plummeting grades and final exams. Patients in their 70s, who have managed symptoms with Adderall for decades, are now forced to switch to other medications, like Ritalin.<\/p>\n Hussaini and her staff at USF Health have worked to help patients adjust treatment plans, but there\u2019s no denying the added stress. Some patients worry what a new plan may mean for their quality of life as shortages continue.<\/p>\n Drug shortages in the U.S. aren\u2019t new, but the past couple of years have brought an all-time high, said Michael Ganio, who directs pharmacy practice and quality for the American Society of Health-System Pharmacists<\/a>, which represents pharmacists nationwide.<\/p>\n The Adderall shortage, Ganio said, is linked to increased demand.<\/p>\n The covid-19 pandemic brought on a flood of new ADHD diagnoses. Studies have found absence of routine and increased screen time may have played a role. With those diagnoses came an increase in stimulant prescriptions, Ganio said \u2014 often via telehealth.<\/p>\n Adderall is a Schedule II controlled substance. It\u2019s highly regulated because of the potential for being diverted for recreational use. Prior to the pandemic, patients were required to have an in-person doctor appointment to get a prescription. But that requirement was waived during the public health emergency, and telehealth appointments were allowed. The telehealth allowance has since been extended<\/a>.<\/p>\n \u201cThere\u2019s a broad group of patients who never had access, or suddenly have easier access, to providers who can make that diagnosis and prescribe,\u201d Ganio said.<\/p>\n Another reason for the shortage are production limitations put in place by the DEA. Each drug manufacturer is effectively given quotas of how much of the drug they can produce. But because manufacturers are shielded by trade secret protections, it can be hard to know whether the DEA quotas are too low or if the manufacturers just aren\u2019t producing to full capacity.<\/p>\n\n\t\t
\n\t\t\tEmail Sign-Up\t\t<\/a>
\n\t<\/h4>\n